LDL anticorps

N° du produit ABIN678548

Détail du produit anti-LDL anticorps

Antigène: LDL (Low Density Lipoprotein (LDL))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp LDL est non-conjugé

Application: Flow Cytometry (FACS), ELISA, Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Frozen Sections) (IHC (fro)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Réactivité croisée: Humain

Homologie: Mouse

Purification: Purified by Protein A.

Immunogène: Full length plasma protein (Human)

Isotype: IgG

Information d'application

Indications d'application: ELISA 1:500-1000
FCM 1:20-100
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.

Date de péremption: 12 months

Références pour anticorps anti-LDL (ABIN678548)

Armstrong, Sugiyama, Fung, Gao, Wang, Levy, Azizi, Roufaiel, Zhu, Neculai, Yin, Bolz, Seidah, Cybulsky, Heit, Lee: "A novel assay uncovers an unexpected role for SR-BI in LDL transcytosis." dans: Cardiovascular research, Vol. 108, Issue 2, pp. 268-77, (2015) (PubMed).

Détails sur LDL

Antigène: LDL (Low Density Lipoprotein (LDL))

Autre désignation: LDL (LDL Produits)

Synonymes: anticorps LDL cholesterol, anticorps LDL

Sujet:

Synonyms: _-Lipoprotein, Low density lipoprotein, apolipoprotein B100, apo-B100

Background: LDL and HDL transport both dietary and endogenous cholesterol in the plasma. LDL is the main transporter of cholesterol and cholesteryl esters and makes up more than half of the total lipoprotein in plasma. LDL is absorbed by the liver and other tissues via receptor mediated endocytosis. The cytoplasmic domain of the LDL receptor facilitates the formation of coated pits, receptor-rich regions of the membrane. The ligand binding domain of the receptor recognizes apo-B100 on LDL, resulting in the formation of a clathrin-coated vesicle. ATP-dependent proton pumps lower the pH inside the vesicle resulting dissociation of LDL from its receptor. After loss of the clathrin coat the vesicles fuse with lysozomes, resulting in peptide and cholesteryl ester enzymatic hydrolysis. The LDL receptor can be recycled to the cell membrane. Insulin, tri-iodothyronine and dexamethasome have shown to be involved with the regulation of LDL receptor mediated uptake. The protein component of LDL is apolipoprotein B100. LDL contains 2022 % protein, 1015 % triglycerides, 2028 % phospholipids, 3748 % cholesteryl esters and 810 % cholesterol.